In 2019, Cambridge Cardiovascular became a Interdisciplinary Research Centre (IRC). We began in 2013, when the University of Cambridge approved a new cross-School activity called Cambridge Cardiovascular Strategic Research Initiative (SRI). This Initiative aims to transform Cambridge into a world-leading hub for cardiovascular research and is open to all cardiovascular researchers in Cambridge area.
Cambridge Cardiovascular acts as an umbrella covering all cardiovascular and related research in Cambridge. Subsets of researchers are members of more focused research centres that are listed below:
- BHF Cambridge Centre for Cardiovascular Research Excellence (BHF CRE)
- BHF Oxbridge Centre of Regenerative Medicine (BHF CRM)
- NIHR Cambridge Biomedical Research Centre Cardiovascular and Respiratory Theme (NIHR BRC)
We also work closely with clinicians at Addenbrooke's and Papworth hospitals, and with local biotech and pharma industry.
Our research community is expanding with the re-location of Papworth hospital and AstraZeneca global headquarters and R&D facilities to Cambridge and the building of a dedicated Victor Phillip Dahdaleh Heart and Lung Research Institute (HLRI)
